These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 2072118

  • 21. The use of concomitant serum pyruvate-kinase (PK) and creatine-phosphokinase (CPK) for carrier detection in Duchenne's muscular dystrophy through discriminant analysis.
    Zatz M, Otto PA.
    J Neurol Sci; 1980 Sep; 47(3):411-7. PubMed ID: 7420115
    [Abstract] [Full Text] [Related]

  • 22. A model to estimate the expression of the dystrophin gene in muscle from female Becker muscular dystrophy carriers.
    Vainzof M, Passos-Bueno MR, Pavanello RC, Schreiber R, Zatz M.
    J Med Genet; 1992 Jul; 29(7):476-9. PubMed ID: 1640426
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Dystrophin as a diagnostic marker in Duchenne and Becker muscular dystrophy. Correlation of immunofluorescence and western blot.
    Voit T, Stuettgen P, Cremer M, Goebel HH.
    Neuropediatrics; 1991 Aug; 22(3):152-62. PubMed ID: 1944822
    [Abstract] [Full Text] [Related]

  • 28. Clinical investigation in Duchenne dystrophy: V. Use of creatine kinase and pyruvate kinase in carrier detection.
    Griggs RC, Mendell JR, Brooke MH, Fenichel GM, Miller JP, Province M, Moxley RT, Huntzinger D, Vaughn A, Cohen M.
    Muscle Nerve; 1985 Jan; 8(1):60-7. PubMed ID: 4058458
    [Abstract] [Full Text] [Related]

  • 29. [Dystrophin in the differentiation between Duchenne and Becker muscular dystrophies: an immunohistochemical study compared with clinical stage, serum enzymes and muscle biopsy].
    Werneck LC, Bonilla E.
    Arq Neuropsiquiatr; 1990 Dec; 48(4):454-64. PubMed ID: 2094192
    [Abstract] [Full Text] [Related]

  • 30. A mathematical analysis of creatine kinase activity in the course of Duchenne muscular dystrophy.
    Pernice W, Guggolz MA, Guggolz M, Beckmann R, Wais U.
    Muscle Nerve; 1986 May; 9(4):333-40. PubMed ID: 3713738
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Serum creatine kinase isoenzymes in Duchenne muscular dystrophy determined by sensitive enzyme immunoassay methods.
    Mokuno K, Riku S, Sugimura K, Takahashi A, Kato K, Osugi S.
    Muscle Nerve; 1987 Jun; 10(5):459-63. PubMed ID: 3302699
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Becker and Duchenne muscular dystrophy: a comparative morphological study.
    Dennett X, Shield LK, Clingan LJ, Woolley DA.
    Aust Paediatr J; 1988 Jun; 24 Suppl 1():15-20. PubMed ID: 3202735
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Alterations in creatine kinase in fresh muscle and cell cultures in Duchenne dystrophy.
    Ionasescu V, Ionasescu R, Feld R, Witte D, Cancilla P, Kaeding L, Stern LZ.
    Ann Neurol; 1981 Apr; 9(4):394-9. PubMed ID: 7224603
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.